Cochrane Urology is dedicated to reviews of the best available evidence (randomized controlled trials or if unavailable controlled clinical trials) of interventions in the diagnosis, prevention, treatment and rehabilitation of benign and malignant prostate conditions (i.e. benign prostatic hyperplasia, prostate cancer, prostatitis), male sexual dysfunction (i.e. erectile dysfunction, undescended testes, Peyronie's disease), benign and malignant urology-related renal topics (renal cancer, stones), and other urological cancers (i.e. bladder, testicular, penile, urethral).
The topic of incontinence is handled by the Cochrane Incontinence Group.